Researcher Profiles

Return to member profile

Tamara Minko, PhD

Publications since 2011

Garbuzenko, O. B. Winkler, J. Tomassone, M. S. Minko, T. Biodegradable Janus Nanoparticles for Local Pulmonary Delivery of Hydrophilic and Hydrophobic Molecules to the Lungs. Langmuir, In process, . (PMID: 25300552)

Huang, X. Tao, Z. Praskavich, J. C. Jr Goswami, A. Al-Sharab, J. F. Minko, T. Polshettiwar, V. Asefa, T. Dendritic Silica Nanomaterials (KCC-1) with Fibrous Pore Structure Possess High DNA Adsorption Capacity and Effectively Deliver Genes In Vitro. Langmuir, In process, . (PMID: 25188675)

Peddada, L. Y. Garbuzenko, O. B. Devore, D. I. Minko, T. Roth, C. M. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes. J Control Release, In process, . (PMID: 25192941)

Savla, R. Garbuzenko, O. B. Chen, S. Rodriguez-Rodriguez, L. Minko, T. Tumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy. Pharm Res, In process, . (PMID: 24919932)

Garbuzenko, O. B. Mainelis, G. Taratula, O. Minko, T. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biol Med, 11:44-55, . (PMID: 24738038, PMCID: PMC3969800)

Xie, X. Bansal, N. Shaik, T. Kerrigan, J. E. Minko, T. Garbuzenko, O. Abali, E. E. Johnson-Farley, N. Banerjee, D. Scotto, K. W. Bertino, J. R. A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget, 5:901-907, . (PMID: 24658650, PMCID: PMC4011592)

Savla, R. Minko, T. Nanotechnology approaches for inhalation treatment of fibrosis. J Drug Target, 21:914-925, . (PMID: 23978292)

Shah, V. Taratula, O. G, O. B. Garbuzenko Taratula, O. R. Rodriguez-Rodriguez, L. Minko, T. Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: an Optimal Delivery of siRNA and Anticancer Drug. Clin Cancer Res, 19:6193-6204, . (PMID: 24036854, PMCID: PMC3846837)

Minko, T. Hatefi, A. Preface-tenth international nanomedicine and drug delivery symposium (NanoDDS'12). J Control Release, 171:259-260, . (PMID: 23954371)

Minko, T. Rodriguez-Rodriguez, L. Pozharov, V. Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Adv Drug Deliv Rev, 65:1880-1895, . (PMID: 24120655)

Minko, T. Nanotechnology and drug resistance. Adv Drug Deliv Rev, 65:1665-1666, . (PMID: 24177352)

Xie, X. Kerrigan, J. E. Minko, T. Garbuzenko, O. Lee, K. C. Scarborough, A. Abali, E. E. Budak-Alpdogan, T. Johnson-Farley, N. Banerjee, D. Scotto, K. W. Bertino, J. R. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Cancer Biol Ther, 14:742-751, . (PMID: 23792570)

Ivanova, V. Garbuzenko, O. B. Reuhl, K. R. Reimer, D. C. Pozharov, V. P. Minko, T. Inhalation Treatment of Pulmonary Fibrosis by Liposomal Prostaglandin E2. Eur J Pharm Biopharm, 84:335-344, . (PMID: 23228437, PMCID: PMC3660419)

Taratula, O. Kuzmov, A. Shah, M. Garbuzenko, O. B. Minko, T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release, In process, . (PMID: 23648833, PMCID: PMC3766401)

Mainelis, G. Seshadri, S. Garbuzenko, O. B. Han, T. Wang, Z. Minko, T. Characterization and Application of a Nose-Only Exposure Chamber for Inhalation Delivery of Liposomal Drugs and Nucleic Acids to Mice. J Aerosol Med Pulm Drug Deliv, In process, . (PMID: 23530772)

Shah, V. Taratula, O. Garbuzenko, O. B. Patil, M. L. Savla, R. Zhang, M. Minko, T. Genotoxicity of Different Nanocarriers: Possible Modifications for the Delivery of Nucleic Acids. Curr Drug Discov Technol, In process, . (PMID: 22564170)

Sheihet, L. Garbuzenko, O. B. Bushman, J. Gounder, M. K. Minko, T. Kohn, J. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor. Eur J Pharm Sci, 45:320-329, . (PMID: 22155544)

Zhang, M. Garbuzenko, O. B. Reuhl, K. R. Rodriguez-Rodriguez, L. Minko, T. Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases. Nanomedicine (Lond), 7:185-197, . (PMID: 22339132)

Nadler-Milbauer, M. Apter, L. Haupt, Y. Haupt, S. Barenholz, Y. Minko, T. Rubinstein, A. Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer. J Drug Target, 19:859-873, . (PMID: 22082104)

Taratula, O. Garbuzenko, O. B. Chen, A. M. Minko, T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J Drug Target, 19:900-914, . (PMID: 21981718)

Dayan, N. Shah, V. Minko, T. Preliminary evaluation of the genotoxic potential of a hydrophilic polymer with three preservation systems. Int J Cosmet Sci, 33:497-502, . (PMID: 21696404)

Savla, R. Taratula, O. Garbuzenko, O. Minko, T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release, 153:16-22, . (PMID: 21342659)

Patil, M. L. Zhang, M. Minko, T. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. ACS Nano, 5:1877-1887, . (PMID: 21322531, PMCID: PMC3062392)

Betigeri, S. Zhang, M. Garbuzenko, O. Minko, T. Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage. Drug Deliv Transl Res, 1:13-24, . (PMID: 21461383, PMCID: PMC3063508)

Dayan, N. Shah, V. Minko, T. Genotoxic potential evaluation of a cosmetic insoluble substance by the micronuclei assay. J Cosmet Sci, 62:29-39, . (PMID: 21443843)

Taratula, O. Garbuzenko, O. Savla, R. Wang, Y. A. He, H. Minko, T. Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Superparamagnetic Iron Oxide Nanoparticles-Dendrimer Complexes. Curr Drug Deliv, 8:59-69, . (PMID: 21034421)